Clinical Trial Update: Korean Multicenter Registry of ELUVIA Stent for Femoropopliteal Artery Disease (K-ELUVIA Registry)

View source ↗

Summary

Clinical trial update on a Korean multicenter registry evaluating the Eluvia paclitaxel-eluting stent for femoropopliteal artery disease, including patients wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Peripheral Artery Disease

Drugs mentioned

• ELUVIA Stent (zotarolimus-eluting stent)

Snippet

Sponsor: Yonsei University | Conditions: Symptomatic Peripheral Artery Disease With Femoropopliteal Lesions, Moderate or Severe Claudication (Rutherford Category 2 or 3) | Status: UNKNOWN